Venture Capital

SkyBeam Venture Partners launches a $250M fund, offering global institutions a new, transparent path to Israel's booming early-stage deep tech sector.

The biotech firm raises cash via a complex warrant deal, diluting shares to fund its promising but challenging RNAi therapy for deadly KRAS-driven cancers.

With an $18M Series A, Arkeus is scaling its AI-powered hyperspectral sensors, giving autonomous military drones unprecedented perception in any environment.

New data reveals TARA-002 has a 55% complete response rate at one year for NMIBC, offering a promising, safer alternative to standard care.

A new oral drug for depression shows rapid, robust effects in a key trial, offering hope for millions by targeting a different brain pathway.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

Figma's revenue growth accelerated to 46% in Q1, driven by the successful monetization of its AI tools and deepening enterprise adoption.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

From the NFL to the NCAA, Robert Turbin's Belen Creative partners with major universities to redefine school spirit through strategic, high-impact merchandise.

As the healthcare industry bleeds talent, PruittHealth's fifth consecutive 'Great Place to Work' award reveals its culture-first strategy for retention and growth.

VR Resources and Athos Metals have launched a massive airborne survey in Ontario, seeking copper, nickel, and PGMs essential for the green economy.

D2C furniture sensation Transformer Table appoints Ashley Global Retail's Chris Wantlin as CEO, signaling a major push into physical stores and global markets.

A strategic alliance between URGE Group and Broadstreet aims to provide the financial backbone for minority-owned developers reshaping Detroit's neighborhoods.

The Nexus Forum launches to connect China's booming biotech scene with global pharma, capitalizing on a major shift in worldwide drug discovery and deal-making.

Senti Biosciences advances its AML cell therapy to a registrational trial after FDA meeting and a key discovery that quadruples patient response rates.

With a fresh $25M in funding, GovWell aims to slash bureaucracy and rebuild public trust by overhauling outdated government systems with a modern AI platform.

With a major new financing round, BlueWind Medical is set to expand access to its innovative Revi® System for urgency urinary incontinence.

With $5M in funding, a new defense startup aims to solve the Navy's cost crisis by building affordable interceptors to counter cheap enemy drones.

Peopoly's new FGF printer slashes costs by up to 90%, making massive, industrial-scale 3D printing accessible to businesses of all sizes.

A US clean tech firm and a UAE emirate are partnering to turn deep rock formations into hydrogen factories, a bold move in the race for clean energy.